2 recruiting, 1 withdrawn. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Withdrawn 1 |
Follow Large B-cell Lymphoma: new trials by email Literature Review of Large B-cell Lymphoma trials Research Report on Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BHB & CAR-T for Lymphomas R-1,3-Butanediol - Large B-cell Lymphoma | Not applicable | Recruiting | Abramson Cancer Center at Penn Medicine | 5 | 2025-01-07 | 2026-02-23 |
| Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers Hematolo-GIST Training, Participants Appointment - Lymphoma, B-Cell, Lymphoma | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 48 | 2023-07-03 | 2026-10-13 |
| Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity Telemedicine visit - Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma | Not applicable | Withdrawn | Wake Forest University Health Sciences | 2020-12-01 | 2020-10-23 |
Lymphoma, Large B-Cell, Diffuse (2) · Dendritic Cell Sarcoma, Interdigitating (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1) · Lymphoma (1) · Lymphoma, B-Cell (1)
Ketones (1) · beta-hydroxybutyrate-1,3-butanediol monoester (1)
Abramson Cancer Center at Penn Medicine (1) · Memorial Sloan Kettering Cancer Center (1) · Wake Forest University Health Sciences (1)
United States (2)
Elise Chong, MD (1) · Kelly McConnell, PhD (1) · Rakhee Vaidya, MBBS (1)